Patents by Inventor Rene HEMMIG

Rene HEMMIG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THYMIC STROMAL LYMPHOPOIETIN (TSLP)-BINDING MOLECULES AND METHODS OF USING THE MOLECULES
    Publication number: 20200325218
    Abstract: The invention provides molecules, e.g., antibodies or antibody fragments, that specifically bind thymic stromal lymphopoietin (TSLP), compositions comprising these molecules, and methods of using and producing these molecules.
    Type: Application
    Filed: July 1, 2020
    Publication date: October 15, 2020
    Inventors: Barbara ANDLAUER, Matthew John EDWARDS, Kapil GUPTA, Nicole HAUBST, Rene HEMMIG, Daniel HUANG, Hans-Peter KNOPF, Danforth MILLER, Jean-Michel Rene RONDEAU, Gino Anselmus VAN HEEKE
  • Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules
    Patent number: 10745473
    Abstract: The invention provides molecules, e.g., antibodies or antibody fragments, that specifically bind thymic stromal lymphopoietin (TSLP), compositions comprising these molecules, and methods of using and producing these molecules.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: August 18, 2020
    Assignee: NOVARTIS AG
    Inventors: Matthew John Edwards, Jean-Michel Rene Rondeau, Danforth Miller, Daniel Huang, Hans-Peter Knopf, Gino Anselmus Van Heeke, Rene Hemmig, Kapil Gupta, Nicole Haubst, Barbara Andlauer
  • THYMIC STROMAL LYMPHOPOIETIN (TSLP)-BINDING MOLECULES AND METHODS OF USING THE MOLECULES
    Publication number: 20180327489
    Abstract: The invention provides molecules, e.g., antibodies or antibody fragments, that specifically bind thymic stromal lymphopoietin (TSLP), compositions comprising these molecules, and methods of using and producing these molecules.
    Type: Application
    Filed: May 8, 2018
    Publication date: November 15, 2018
    Applicant: NOVARTIS AG
    Inventors: Matthew John EDWARDS, Jean-Michel Rene RONDEAU, Danforth MILLER, Daniel HUANG, Hans-Peter KNOPF, Gino Anselmus VAN HEEKE, Rene HEMMIG, Kapil GUPTA, Nicole HAUBST, Barbara ANDLAUER
  • Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules
    Patent number: 10000561
    Abstract: The invention provides molecules, e.g., antibodies or antibody fragments, that specifically bind thymic stromal lymphopoietin (TSLP), compositions comprising these molecules, and methods of using and producing these molecules.
    Type: Grant
    Filed: September 7, 2016
    Date of Patent: June 19, 2018
    Assignee: NOVARTIS AG
    Inventors: Matthew John Edwards, Jean-Michel Rene Rondeau, Danforth Miller, Daniel Huang, Hans-Peter Knopf, Gino Anselmus Van Heeke, Rene Hemmig, Kapil Gupta, Nicole Haubst, Barbara Andlauer
  • THYMIC STROMAL LYMPHOPOIETIN (TSLP)-BINDING MOLECULES AND METHODS OF USING THE MOLECULES
    Publication number: 20170066823
    Abstract: The invention provides molecules, e.g., antibodies or antibody fragments, that specifically bind thymic stromal lymphopoietin (TSLP), compositions comprising these molecules, and methods of using and producing these molecules.
    Type: Application
    Filed: September 7, 2016
    Publication date: March 9, 2017
    Inventors: Matthew John EDWARDS, Jean-Michel Rene RONDEAU, Danforth Miller, Daniel Huang, Hans-Peter KNOPF, Gino Anselmus VAN HEEKE, Rene HEMMIG, Kapil GUPTA, Nicole HAUBST, Barbara ANDLAUER